BioCentury
ARTICLE | Company News

Synthetic Genomics, Gen9 deal

July 13, 2015 7:00 AM UTC

Synthetic Genomics granted Gen9 non-exclusive, worldwide rights to use methods for parallelized, low-cost oligonucleotide synthesis and sequence-validated DNA retrieval. Synthetic Genomics has worldwi...